ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

Funding Opportunity: Leukemia & Lymphoma Society Launches Myeloid Program

October 31, 2014

In Brief: Freireich On Nutrition: Diet Can Affect Immune System, Effectiveness Of Cancer Drugs

September 12, 1975

Insurers Increasingly Willing To Cover ABMT For Breast Cancer, GAO Finds

June 7, 1996

DCT Survey Shatters Myth That Young Investigator Have Difficulty Getting Grants – They’re Doing Better Than Those Over Age 40

August 3, 1984

Jako Bows Out with Blast At NCI, Calls For IOM Review Of Cancer Program

April 15, 1988

Endoscopic Surgery Provides Equal Or Better Results

September 30, 2005